Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells

BMC Cancer201717:889

https://doi.org/10.1186/s12885-017-3932-y

Received: 4 July 2017

Accepted: 18 December 2017

Published: 28 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
4 Jul 2017 Submitted Original manuscript
15 Sep 2017 Reviewed Reviewer Report - François D. Boussin
25 Sep 2017 Reviewed Reviewer Report - Nobuo Sakaguchi
1 Dec 2017 Author responded Author comments - Marina Conde
Resubmission - Version 2
1 Dec 2017 Submitted Manuscript version 2
14 Dec 2017 Author responded Author comments - Marina Conde
Resubmission - Version 3
14 Dec 2017 Submitted Manuscript version 3
Publishing
18 Dec 2017 Editorially accepted
28 Dec 2017 Article published 10.1186/s12885-017-3932-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Neurosurgery, Section Experimental Neurosurgery/Tumor Immunology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
(2)
Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany
(3)
German Cancer Consortium (DKTK), partner site Dresden; German Cancer Research Center (DKFZ), Heidelberg, Germany
(4)
National Center for Tumor Diseases (NCT), Dresden, Germany

Advertisement